Peck Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 M
- Revenue Growth 48.03%
- Profit Growth 44.43%
- Ebitda 53.23%
- Net Worth 65.18%
- Total Assets 13.80%
About Peck Biotech
Peck Biotech Private Limited (PBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 01 March 2013 and has a history of 11 years and 11 months. Its registered office is in Khorda, Odisha, India.
The Corporate was formerly known as Kalvik Auto Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.00 M.
Gyanendra Rout and Santilata Rout serve as directors at the Company.
Company Details
-
Location
Khorda, Odisha, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U50400OR2013PTC016603
-
Company No.
016603
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Mar 2013
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Cuttack
Industry
Who are the key members and board of directors at Peck Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gyanendra Rout
|
Managing Director | 01-Mar-2013 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Santilata Rout
|
Director | 01-Mar-2013 | Current |
Financial Performance of Peck Biotech.
Peck Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 48.03% increase. The company also saw a substantial improvement in profitability, with a 44.43% increase in profit. The company's net worth Soared by an impressive increase of 65.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Peck Biotech?
In 2021, Peck Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Kalvik Builders Private LimitedSantilata Rout is a mutual person
-
Blue Ocean E-Commerce Private LimitedSantilata Rout is a mutual person
-
Bluehubb Manufacturing And Trading Private LimitedSantilata Rout is a mutual person
Charges (Loans)
₹5.00 M
₹0
Charges Breakdown by Lending Institutions
- Uco Bank : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Sep 2013 | Uco Bank | ₹5.00 M | Open |
How Many Employees Work at Peck Biotech?
Unlock and access historical data on people associated with Peck Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Peck Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Peck Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.